Objectives: Sacrococcygeal teratoma (SCT) tumours are often highly vascularised and may result in high-output cardiac failure, polyhydramnios, fetal hydrops and demise. Fetal surgical outcomes are poor and current management is expectant, balancing risk of sudden hydrops and death against premature delivery. Delivery is guided by SCT:fetus volume ratio (SCTratio), SCT growth rate, and cardiac output indexed for weight (CCOi). We hypothesised SCT vascularisation index (VI%) and modelling systemic and umbilical venous volumes (SCTModel) may be better indicators. Methods: We compared measurements and outcome in 12 consecutive fetuses referred with SCT. Adverse outcomes were: fetal surgery, delivery <32 gestational weeks (gw) or neonatal demise (NND). Only SCTratio and CCOi were used to manage the cases. VI% was derived from 3D virtual organ computer aided analysis (VOCAL) software. The SCTModel (modified from acardiac twins) calculated a hypothetical SCT draining vein size and derived a risk line, using diameters of superior and inferior vena cava, azygous and umbilical veins. From this excess cardiac output required to perfuse the SCT (XSCO%) was derived. Statistical analysis used mixed models with subject as random effect with F statistic to compare groups, two-sided p-value<0.05 was significant. Results: Fetuses were monitored from 20.1 to 36.4 weeks and 5/12 had adverse outcomes: 1 successful open fetal surgery at 23.8 weeks, 4 delivered <32 weeks with 3/4 NND (25-29 gw). VI% was significantly higher in adverse cases (mean 10.3 vs 4.4, p<0.0001). SCTratio (p=0.08) and CCOi (p=0.64) were not significant. All adverse cases had VI% >8%. XSCO% and SCTModel risk line predicted non-adverse outcomes well, but lacked data in 2/5 adverse cases. Conclusions: VI% is a significant indicator of adverse SCT cases and combined with SCTratio may guide timing of delivery better than current measures. The SCTModel shows promise, but needs further development. Objectives: To perform the external validation of IOTA's three-step strategy for classifying adnexal masses as benign or malignant, when ultrasound is performed by non-expert sonographers. Methods: Prospective observational study conducted at two university hospitals in Spain. We included patients with an adnexal mass that was assessed by ultrasound through the three-step strategy: non-expert sonographers applied the first step (simple descriptors) and the second step (simple rules; if the mass could not be classified with the first step) and an expert sonographer made the subjective assessment of the mass if it could not be classified with the first two steps. None of the patients included in this study had been included in previous IOTA studies. Patients had to undergo surgery or at least twelve months of follow-up. Definitive histology after tumour removal or data from 12 months follow-up were used as reference standard. Results: Two hundred and eighty-three patients were included (median age 48). One hundred and sixty-five patients (58.3%) were premenopausal and 118 (41.7%) postmenopausal. Two hundred and sixteen women (76.3%) underwent surgical treatment (154 benign and 62 malignant) and 67 (23.7%) performed expectant monitoring for at least 12 months (all these masses were considered benign because no sonographic characteristic changes of malignancy were observed). Simple descriptors could be applied in 126 (44.5%) masses. Of the remaining 157 lesions, 112 (71.3%) could be characterised using simple rules. Of the remaining 45 (16.0%) masses, all could be classified by an expert sonographer. Therefore, 238 (84%) masses could be classified using the first two steps by non-expert sonographers. The diagnostic performance of the three-step strategy was: sensitivity 95.1%; specificity 97.7%; positive likelihood ratio 42.1 and negative likelihood ratio 0.05. The diagnostic accuracy was 97.1%. Conclusions: The IOTA three-step strategy shows good accuracy in the classification of adnexal lesions when used by non-expert sonographers.
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Objectives: Accurate characterisation of ovarian masses, which often presents late, is critical to optimising patient outcomes. The introduction of the International Ovarian Tumour Analysis (IOTA) rules has provided some consistency in defining morphological features of ovarian masses through standardised sonographic examinations. The purpose of this study is to evaluate the diagnostic performance of IOTA logistic regression model (LR2) in distinguishing benign and malignant ovarian tumours and establishing their use as a diagnostic tool in ovarian malignancy.
